A simple prognostic score based on troponin and presepsin for COVID-19 patients admitted to the emergency department: a single-center pilot study
- PMID: 34487072
- PMCID: PMC8477102
- DOI: 10.23750/abm.v92i4.11479
A simple prognostic score based on troponin and presepsin for COVID-19 patients admitted to the emergency department: a single-center pilot study
Abstract
Background: The need to determine prognostic factors that can predict a particularly severe or, conversely, the benign course of COVID-19 is particularly perceived in the Emergency Department (ED), considering the scarcity of resources for a conspicuous mass of patients. The aim of our study was to identify some predictors for 30-day mortality among some clinical, laboratory, and ultrasound variables in a COVID-19 patients population.
Methods: Prospective single-center pilot study conducted in an ED of a University Hospital. A consecutive sample of confirmed COVID-19 patients with acute respiratory failure was enrolled from March 8th to April 15th, 2020.
Results: 143 patients were enrolled. Deceased patients (n = 65) were older (81 vs. 61 years, p <0.001), and they had more frequently a history of heart disease, neurological disease, or chronic obstructive pulmonary disease (p-values = 0.026, 0.025, and 0.034, respectively) than survived patients. Troponin I and presepsin had a significant correlation with a worse outcome. Troponin achieved a sensitivity of 77% and a specificity of 82% for a cut-off value of 27.6 ng/L. The presepsin achieved a sensitivity of 54% and a specificity of 92% for a cut-off value of 871 pg/mL.
Conclusion: In a population of COVID-19 patients with acute respiratory failure in an ED, presepsin and troponin I are accurate predictors of 30-day mortality. Presepsin is highly specific and could permit the early identification of patients who could benefit from more intensive care as soon as they enter the ED. Further validation studies are needed to confirm this result.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
Figures



Similar articles
-
Presepsin as a prognostic biomarker in COVID-19 patients: combining clinical scoring systems and laboratory inflammatory markers for outcome prediction.Virol J. 2024 Apr 26;21(1):96. doi: 10.1186/s12985-024-02367-1. Virol J. 2024. PMID: 38671532 Free PMC article.
-
Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.Crit Care. 2013 Oct 20;17(5):R244. doi: 10.1186/cc13070. Crit Care. 2013. PMID: 24138799 Free PMC article.
-
Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.Ann Lab Med. 2022 Jul 1;42(4):406-414. doi: 10.3343/alm.2022.42.4.406. Ann Lab Med. 2022. PMID: 35177561 Free PMC article.
-
Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.Crit Care. 2013 Jul 30;17(4):R168. doi: 10.1186/cc12847. Crit Care. 2013. PMID: 23899120 Free PMC article.
-
Diagnostic accuracy of presepsin in predicting bacteraemia in elderly patients admitted to the emergency department: prospective study in Japan.BMJ Open. 2019 Dec 15;9(12):e030421. doi: 10.1136/bmjopen-2019-030421. BMJ Open. 2019. PMID: 31843822 Free PMC article.
Cited by
-
Presepsin in Critical Illness: Current Knowledge and Future Perspectives.Diagnostics (Basel). 2024 Jun 20;14(12):1311. doi: 10.3390/diagnostics14121311. Diagnostics (Basel). 2024. PMID: 38928726 Free PMC article. Review.
-
Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19).Int J Hematol. 2023 Jun;117(6):845-855. doi: 10.1007/s12185-023-03555-5. Epub 2023 Mar 15. Int J Hematol. 2023. PMID: 36920687 Free PMC article.
-
Factors Associated with ICU Admission in Patients with COVID-19: The GOL2DS Score.Medicina (Kaunas). 2021 Dec 12;57(12):1356. doi: 10.3390/medicina57121356. Medicina (Kaunas). 2021. PMID: 34946301 Free PMC article.
-
Point-of-care Lung Ultrasound, Lung CT and NEWS to Predict Adverse Outcomes and Mortality in COVID-19 Associated Pneumonia.J Intensive Care Med. 2022 Dec;37(12):1614-1624. doi: 10.1177/08850666221111731. Epub 2022 Nov 1. J Intensive Care Med. 2022. PMID: 36317355 Free PMC article.
-
Presepsin as a prognostic biomarker in COVID-19 patients: combining clinical scoring systems and laboratory inflammatory markers for outcome prediction.Virol J. 2024 Apr 26;21(1):96. doi: 10.1186/s12985-024-02367-1. Virol J. 2024. PMID: 38671532 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous